WallStreetZenWallStreetZen

NASDAQ: CUTR
Cutera Inc Stock

$1.67+0.01 (+0.6%)
Updated Jul 17, 2024
CUTR Price
$1.67
Fair Value Price
N/A
Market Cap
$33.52M
52 Week Low
$1.28
52 Week High
$21.41
P/E
-0.21x
P/B
-0.17x
P/S
0.15x
PEG
N/A
Dividend Yield
N/A
Revenue
$196.64M
Earnings
-$157.56M
Gross Margin
16.4%
Operating Margin
-73.51%
Profit Margin
-80.1%
Debt to Equity
-2.62
Operating Cash Flow
-$138M
Beta
1.28
Next Earnings
Aug 6, 2024
Ex-Dividend
N/A
Next Dividend
N/A

CUTR Overview

Cutera, Inc., a medical device company, researches, develops, manufactures, markets, and services laser and energy-based aesthetics systems for practitioners worldwide. The company offers Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for deep dermal remodeling; truSculpt flex, a bio-electrical muscle stimulation device to treat patients at all fitness levels; excel V+, a vascular and benign pigmented lesion treatment platform; truSculpt iD, for the non-surgical body sculpting market; and Secret RF, a fractional RF microneedling system for tissue coagulation and hemostasis. It also provides enlighten platform, a laser system that is used for tattoo removal, as well as to treat benign pigmented lesions and acne scars; excel HR platform, a hair removal solution for various skin types; and xeo platform, a multi-application platform on which a customer purchases hand piece applications for the removal of unwanted hair, treatment of vascular lesions, and skin revitalization by treating discoloration, fine lines, and laxity. In addition, the company distributes skincare products; and offers post-warranty services through extended service contracts or direct billing. Further, it provides pulsed light hand pieces for the treatment of discoloration, hair removal, and vascular treatments; and Pearl and Pearl Fractional hand pieces, as well as sells hand piece refills, cycle refills, consumable tips, and marketing brochures through the company's website. The company markets and sells its products through direct sales force to plastic surgeons, dermatologists, gynecologists, family practitioners, primary care physicians, and other qualified practitioners, as well as for physicians performing aesthetic treatments in non-medical offices. Cutera, Inc. was incorporated in 1988 and is headquartered in Brisbane, California.

Zen Score

Industry Average (27)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how CUTR scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

CUTR is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
CUTR is unprofitable, so we are unable to assess its PEG ratio
PEG Value Valuation
CUTR's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
There are 30 more CUTR due diligence checks available for Premium users.

Be the first to know about important CUTR news, forecast changes, insider trades & much more!

CUTR News

Valuation

CUTR price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.21x
Industry
30.16x
Market
30.24x

CUTR price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
-0.17x
Industry
3.92x

CUTR's financial health

Profit margin

Revenue
$38.8M
Net Income
-$22.8M
Profit Margin
-58.7%
CUTR's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
CUTR's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$312.0M
Liabilities
$504.6M
Debt to equity
-2.62
CUTR's short-term assets ($235.23M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CUTR's long-term liabilities ($431.85M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CUTR's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
CUTR's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$37.6M
Investing
-$278.0k
Financing
-$260.0k
CUTR's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

CUTR vs Medical Device Stocks

TickerMarket Cap1d %P/EP/B
CUTR$33.52M+0.60%-0.21x-0.17x
MDAI$33.39M+2.14%-1.63x-16.47x
LFWD$34.15M+1.02%-1.40x0.84x
TLIS$32.56M-1.61%-0.27x0.57x
IRIX$32.51M-6.10%-2.99x5.01x

Cutera Stock FAQ

What is Cutera's quote symbol?

(NASDAQ: CUTR) Cutera trades on the NASDAQ under the ticker symbol CUTR. Cutera stock quotes can also be displayed as NASDAQ: CUTR.

If you're new to stock investing, here's how to buy Cutera stock.

What is the 52 week high and low for Cutera (NASDAQ: CUTR)?

(NASDAQ: CUTR) Cutera's 52-week high was $21.41, and its 52-week low was $1.28. It is currently -92.2% from its 52-week high and 30.47% from its 52-week low.

How much is Cutera stock worth today?

(NASDAQ: CUTR) Cutera currently has 20,072,096 outstanding shares. With Cutera stock trading at $1.67 per share, the total value of Cutera stock (market capitalization) is $33.52M.

Cutera stock was originally listed at a price of $14.00 in Mar 31, 2004. If you had invested in Cutera stock at $14.00, your return over the last 20 years would have been -88.07%, for an annualized return of -10.09% (not including any dividends or dividend reinvestments).

How much is Cutera's stock price per share?

(NASDAQ: CUTR) Cutera stock price per share is $1.67 today (as of Jul 17, 2024).

What is Cutera's Market Cap?

(NASDAQ: CUTR) Cutera's market cap is $33.52M, as of Jul 18, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Cutera's market cap is calculated by multiplying CUTR's current stock price of $1.67 by CUTR's total outstanding shares of 20,072,096.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.